CinCor Pharma, Inc.
CinCor Pharma, Inc. (CINC) Revenue
Annual & quarterly revenue history · segment & region breakdown
CINC · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsCinCor Pharma, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from $0.00B in FY2021.
Revenue trend
2021 – 2019 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2021-12-31 | $0.00B | +$0.00B | — |
| 2020-12-31 | $0.00B | +$0.00B | — |
| 2019-12-31 | $0.00B | — | — |
Compare revenue vs peers
BiotechnologyCompare CINC revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income CinCor Pharma, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
CinCor Pharma, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from CinCor Pharma, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
CINC revenue · 4 questionsCINC's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from $0.00B in FY2021.
▸ Source: FMP · CinCor Pharma, Inc. SEC filings · GAAP · CinCor Pharma, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026